Viewing Study NCT00489151


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2026-03-14 @ 8:21 AM
Study NCT ID: NCT00489151
Status: UNKNOWN
Last Update Posted: 2010-07-07
First Post: 2007-06-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy
Sponsor: Hospital Authority, Hong Kong
Organization:

Organization Data

Organization:
Class: OTHER_GOV
Study ID: UW 04-315 T/637
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View